Fed rate hike and persistent inflation put broker-favored Beazer Homes, Best Buy, Alaska Air, RXO and AMN Healthcare stocks in focus.
AMN Healthcare is emerging from a post-pandemic demand normalization, with Q2 2026 revenue growing 2.3% year-over-year and gross margin expanding to 30.6%, suggesting a potential bottom in the cycle. However, the recovery is fragile: operating margin remains t...
Price trend, volume and key moving averages
Trailing total returns as of 10/2/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC).
Check whether operating performance supports the current valuation.
Recent results and news deserve attention only when they alter the forward view.
| Quarter | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|
Q3 2026Latest Aug 6, 2026 | $0.77+307.8% vs $0.19 | $673M+7.1% vs $628M |
Q2 2026 May 7, 2026 | $2.10+31.3% vs $1.60 | $1.4B+11.7% vs $1.2B |
Q1 2026 Feb 19, 2026 | $0.22+0.0% vs $0.22 | $748M+3.4% vs $724M |
Q4 2025 Nov 6, 2025 | $0.39+105.3% vs $0.19 | $634M-12.3% vs $723M |
Fed rate hike and persistent inflation put broker-favored Beazer Homes, Best Buy, Alaska Air, RXO and AMN Healthcare stocks in focus.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Tidal Investments LLC acquired a new position in AMN Healthcare Services Inc (NYSE: AMN) during the undefined quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm acquired 71,097 shares of the company's stock, valued at approximately $2,301,000. Tidal Investments LLC owned 0.18% of AMN
Investors need to pay close attention to AMN stock based on the movements in the options market lately.
Benchmark AMN against direct peers instead of judging its metrics in isolation.
Key metrics vs top competitors for AMN Healthcare Services, Inc. (AMN)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $35.86 | $1.39B | -14.46 | -8.49% | -3.5% | -14.19% | — | |
| $502.90 | $6.68B | 27.30 | 4.06% | 10.6% | 29.45% | — | |
| $13.25 | $428.06M | -4.52 | -21.56% | -9.84% | -27.1% | — | |
| $9.48 | $288.23M | -5.89 | 3.1% | -3.35% | -20.78% | — | |
| $20.58 | $1.41B | 25.41 | 7.08% | 6.59% | 24.12% | — | |
| $53.53 | $2.81B | 9.72 | 2.36% | 7.07% | 21.72% | — |
AMN Healthcare Services, Inc. (AMN) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Verify the primary filings, follow material updates, and answer the remaining questions.
AMN Healthcare Services, Inc. (AMN) SEC filings — annual & quarterly reports (10-K, 10-Q)
Aug 6, 2026·SEC
May 7, 2026·SEC
May 4, 2026·SEC
Get notified when AMN posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
AMN Healthcare Services, Inc. (AMN) stock FAQ — growth, dividends, profitability & financials explained
AMN Healthcare Services, Inc. (AMN) reported $3.43B in revenue for fiscal year 2025. This represents a 1388% increase from $230.8M in 2000.
AMN Healthcare Services, Inc. (AMN) saw revenue decline by 8.5% over the past year.
Yes, AMN Healthcare Services, Inc. (AMN) is profitable, generating $104.9M in net income for fiscal year 2025 (-3.5% net margin).
AMN Healthcare Services, Inc. (AMN) has a return on equity (ROE) of -14.2%. Negative ROE indicates the company is unprofitable.
AMN Healthcare Services, Inc. (AMN) generated $439.1M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.